COMMERZBANK AKTIENGESELLSCHAFT /FI - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2019$573,000
+3.1%
20,0000.0%0.01%
+25.0%
Q2 2019$556,000
-16.3%
20,0000.0%0.00%
-42.9%
Q1 2019$664,000
+14.3%
20,0000.0%0.01%
+16.7%
Q4 2018$581,000
-36.8%
20,0000.0%0.01%
-33.3%
Q3 2018$920,000
+23.2%
20,0000.0%0.01%
+12.5%
Q2 2018$747,000
+26.4%
20,0000.0%0.01%
+14.3%
Q1 2018$591,000
-14.0%
20,0000.0%0.01%
-22.2%
Q4 2017$687,000
-5.1%
20,0000.0%0.01%
-10.0%
Q3 2017$724,000
+40.0%
20,0000.0%0.01%
+11.1%
Q2 2017$517,000
+24.0%
20,000
-8.0%
0.01%
+50.0%
Q1 2017$417,000
+17.1%
21,733
+1.7%
0.01%
+20.0%
Q4 2016$356,000
-18.0%
21,376
+1.4%
0.01%
-28.6%
Q3 2016$434,000
-46.9%
21,075
-21.2%
0.01%
+16.7%
Q2 2016$818,000
-18.7%
26,737
-0.5%
0.01%
-25.0%
Q1 2016$1,006,000
+5.9%
26,883
+22.2%
0.01%
+14.3%
Q4 2015$950,000
+107.9%
22,004
+80.4%
0.01%
+133.3%
Q3 2015$457,000
-46.3%
12,200
-51.3%
0.00%
-25.0%
Q2 2015$851,000
-5.4%
25,027
-1.6%
0.00%
-20.0%
Q1 2015$900,000
+214.7%
25,434
+202.4%
0.01%
+150.0%
Q4 2014$286,000
-60.7%
8,410
-55.4%
0.00%
-33.3%
Q3 2014$727,000
+251.2%
18,845
+145.1%
0.00%
+200.0%
Q2 2013$207,0007,6890.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders